Breaking News Instant updates and real-time market news.

AMD

AMD

$20.18

0.46 (2.33%)

10:50
08/14/18
08/14
10:50
08/14/18
10:50

In-the-money vertical call spread sale in AMD with shares at 10 year highs

In-the-money vertical call spread sale in AMD with shares at 10 year highs. Shares lifted as high as $20.28 for the first time since 2007, with a notable block trading on the PHLX where a customer sold 12K Aug 18/19.5 call spreads, outright, for $1.33. Shares have nearly doubled in price this year, and today's trade likely exits a long entered mid-June when shares stalled out near $16 and similar size was bought to open near $1.

  • 28

    Aug

  • 12

    Sep

AMD AMD
$20.18

0.46 (2.33%)

08/10/18
GSCO
08/10/18
UPGRADE
Target $21
GSCO
Neutral
AMD upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Toshiya Hari upgraded AMD (AMD) to Neutral from Sell and raised his price target for the shares to $21 from $13.25. The chipmaker closed yesterday down 48c to $19.10. Intel's (INTC) struggles with 10nm process technology make it increasingly harder to argue for a bear thesis, even following the recent rally in the shares, Hari tells investors in a research note. The analyst admits, however, that he still has concerns related to AMD's graphics processing unit business given the continued decline in cryptocurrency mining demand and increased competition from Nvidia (NVDA). Nevertheless, the delay in Intel's new products will allow AMD to gain share in not only client computer processing units, but also in the "lucrative" server CPU market, Hari contends. He believes this makes for a balanced risk/reward profile on AMD shares.
08/10/18
GSCO
08/10/18
DOWNGRADE
GSCO
Sell
Intel downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Toshiya Hari downgraded Intel (INTC) to Sell from Neutral and lowered his price target for the shares to $44 from $49. The chipmaker closed yesterday up 18c to $50.14. Hari coupled the downgrade with an upgrade of AMD (AMD) to Neutral from Sell. Intel's struggles with 10nm process technology makes the analyst incrementally more negative on the company's competitive positioning and margin outlook. He expects a worsening product mix in the near-term, ramp in 10nm costs and growing depreciation to drive margin pressure and Intel's earnings below consensus expectations. Hari sees downside risk in the shares.
08/10/18
08/10/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AMD (AMD) upgraded to Neutral from Sell at Goldman Sachs with analyst Toshiya Hari saying Intel's (INTC) struggles with 10nm process technology make it increasingly harder to argue for a bear thesis, even following the recent rally in the shares. 2. RBS (RBS) upgraded to Buy from Neutral at UBS with analyst Jason Napier saying the bank's capital strength is being undervalued by the market. 3. Dropbox (DBX) upgraded to Outperform from Sector Perform at RBC Capital with analyst Mark Mahaney citing "strong" Q2 results and above consensus guidance. 4. Sanofi (SNY) upgraded to Buy from Neutral at Citi. 5. Floor & Decor (FND) upgraded to Outperform from Market Perform at Wells Fargo with analyst Zachary Fadem saying he believes current share levels represent a "compelling long-term entry point for one of the best growth stories in all of retail." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/10/18
08/10/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. GOLDMAN CUTS INTEL, UPGRADES AMD: Goldman Sachs analyst Toshiya Hari downgraded Intel (INTC) to Sell from Neutral and lowered his price target for the shares to $44 from $49. Hari coupled the downgrade with an upgrade of AMD (AMD) to Neutral from Sell. Intel's struggles with 10nm process technology made the analyst incrementally more negative on the company's competitive positioning and margin outlook. He expects a worsening product mix in the near-term, ramp in 10nm costs and growing depreciation to drive margin pressure and Intel's earnings below consensus expectations. The delay in Intel's new products will allow AMD to gain share in not only client computer processing units, and also in the "lucrative" server CPU market, Hari contended. He believes this makes for a balanced risk/reward profile on AMD shares. In late morning trading, Intel is down 2.5% and AMD is up fractionally. BOOKING HOLDINGS DOWNGRADED AT MULTIPLE FIRMS: UBS analyst Eric Sheridan downgraded Booking Holdings (BKNG) to Neutral from Buy and lowered his price target for the shares to $2,060 from $2,320 following the company's Q2 results. JPMorgan analyst Doug Anmuth downgraded Booking Holdings to Neutral from Overweight and lowered his price target for the shares to $2,070 from $2,385. Additionally, Citi analyst Mark May downgraded Booking Holdings to Neutral from Buy and lowered his price target for the shares to $2,150 from $2,350. Booking Holding is down over 2% in late morning trading. JPMORGAN CUTS CAMPBELL SOUP TO UNDERWEIGHT: JPMorgan analyst Ken Goldman downgraded Campbell Soup (CPB) to Underweight from Neutral with a $36 price target, saying he believes a sale of the company at a significant premium is unlikely. Campbell Soup is down over 2% in late morning trading. CANTOR SEES MANY REASONS FOR UNITEDHEALTH ACQUIRING ATHENAHEALTH: Numerous media sources cited a Dealreporter story indicating that UnitedHealth (UNH) is now in the second round of bidding for Athenahealth (ATHN), Cantor Fitzgerald analyst Steven Halper said in a research note. There are "many reasons" why UnitedHealth's Optum would benefit from the acquisition of Athenahealth, the analyst contended. With or without the deal, the analyst expects UnitedHealth will deploy capital and grow its various Optum businesses over time. He reiterated an Overweight rating on shares with a $300 price target.

TODAY'S FREE FLY STORIES

ALGT

Allegiant Travel

$124.89

-1.45 (-1.15%)

18:37
12/10/18
12/10
18:37
12/10/18
18:37
Hot Stocks
Allegiant reports November total systems traffic up 10.1% »

Reports total systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPLK

Splunk

$108.55

2.85 (2.70%)

18:27
12/10/18
12/10
18:27
12/10/18
18:27
Periodicals
Splunk CEO says customers can now talk via voice-enabled assistants, CNBC says »

Splunk president and CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 19

    Dec

  • 20

    Dec

  • 09

    Jan

EFC

Ellington Financial

$15.57

0.01 (0.06%)

18:22
12/10/18
12/10
18:22
12/10/18
18:22
Hot Stocks
Ellington Financial reports book value per share of $19.37 as of Nov. 30th »

Ellington Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTDOY

Nintendo

$0.00

(0.00%)

18:22
12/10/18
12/10
18:22
12/10/18
18:22
Periodicals
New 'Smash Bros.' fastest selling Switch game so far, Gamesindustry.biz says »

Nintendo's latest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,040.02

3.5 (0.34%)

, GOOGL

Alphabet Class A

$1,052.80

5.81 (0.55%)

18:15
12/10/18
12/10
18:15
12/10/18
18:15
Periodicals
Google CEO supports privacy law, denies political bias, Bloomberg says »

Google CEO Sundar Pichai…

GOOG

Alphabet

$1,040.02

3.5 (0.34%)

GOOGL

Alphabet Class A

$1,052.80

5.81 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 03

    Mar

APTI

Apptio

$37.86

-0.17 (-0.45%)

18:13
12/10/18
12/10
18:13
12/10/18
18:13
Downgrade
Apptio rating change  »

Apptio downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NMRK

Newmark

$8.56

0.21 (2.52%)

18:00
12/10/18
12/10
18:00
12/10/18
18:00
Hot Stocks
Newmark CEO Barry Gosin buys over $2.6M in company shares »

Newmark CEO Barry Gosin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVTC

Evertec

$26.83

-0.365 (-1.34%)

17:52
12/10/18
12/10
17:52
12/10/18
17:52
Hot Stocks
Evertec EVP Ramirez sells 44,378 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 18

    Dec

ALTM

Altus Midstream Company

$8.50

0.6 (7.59%)

, APA

Apache

$31.27

-1.74 (-5.27%)

17:46
12/10/18
12/10
17:46
12/10/18
17:46
Hot Stocks
Apache reports 13.4% stake in Altus Midstream Company »

This stake allows for…

ALTM

Altus Midstream Company

$8.50

0.6 (7.59%)

APA

Apache

$31.27

-1.74 (-5.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHT

Red Hat

$177.13

0.03 (0.02%)

, IBM

IBM

$121.13

1.77 (1.48%)

17:45
12/10/18
12/10
17:45
12/10/18
17:45
Hot Stocks
Red Hat sets January 16 special meeting for vote on IBM merger »

Red Hat, Inc. (RHT)…

RHT

Red Hat

$177.13

0.03 (0.02%)

IBM

IBM

$121.13

1.77 (1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

YMAB

Y-mAbs Therapeutics

$22.17

-0.36 (-1.60%)

17:42
12/10/18
12/10
17:42
12/10/18
17:42
Hot Stocks
Y-mAbs Therapeutics humanized bispecific GD2 antibody IND receives FDA clearance »

Y-mAbs Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Shares

$117.68

-0.39 (-0.33%)

17:39
12/10/18
12/10
17:39
12/10/18
17:39
Hot Stocks
SPDR Gold Shares holdings rise to 760.32MT from 759.73MT »

This is the second…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAEX

SAExploration

$3.33

-0.11 (-3.20%)

17:35
12/10/18
12/10
17:35
12/10/18
17:35
Syndicate
SAExploration files to sell common stock for holders »

SAExploration filed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHVN

Biohaven Pharmaceutical

$40.47

-0.25 (-0.61%)

17:27
12/10/18
12/10
17:27
12/10/18
17:27
Syndicate
Breaking Syndicate news story on Biohaven Pharmaceutical »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WCC

Wesco

$49.28

-0.675 (-1.35%)

17:26
12/10/18
12/10
17:26
12/10/18
17:26
Initiation
Wesco initiated  »

Wesco initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

MTEM

Molecular Templates

$4.30

-0.08 (-1.83%)

17:25
12/10/18
12/10
17:25
12/10/18
17:25
Initiation
Molecular Templates initiated  »

Molecular Templates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

COHR

Coherent

$119.34

-0.28 (-0.23%)

17:23
12/10/18
12/10
17:23
12/10/18
17:23
Initiation
Coherent initiated  »

Coherent initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAMP

CalAmp

$17.02

-0.23 (-1.33%)

17:22
12/10/18
12/10
17:22
12/10/18
17:22
Hot Stocks
CalAmp announces $20M stock repurchase program »

CalAmp announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CR

Crane

$78.23

-0.99 (-1.25%)

17:22
12/10/18
12/10
17:22
12/10/18
17:22
Initiation
Crane initiated  »

Crane initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTX

BioTime

$1.31

-0.03 (-2.24%)

17:22
12/10/18
12/10
17:22
12/10/18
17:22
Initiation
BioTime initiated  »

BioTime initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVAX

Novavax

$2.14

0.09 (4.39%)

17:20
12/10/18
12/10
17:20
12/10/18
17:20
Initiation
Novavax initiated  »

Novavax initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$207.84

-3.275 (-1.55%)

17:19
12/10/18
12/10
17:19
12/10/18
17:19
Initiation
Lennox initiated  »

Lennox initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

FCAU

Fiat Chrysler

$15.33

(0.00%)

17:17
12/10/18
12/10
17:17
12/10/18
17:17
Hot Stocks
Breaking Hot Stocks news story on Fiat Chrysler »

Tiger Global reports 5.1%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$169.61

1.24 (0.74%)

17:15
12/10/18
12/10
17:15
12/10/18
17:15
Recommendations
Apple analyst commentary  »

Apple pullback is a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWK

Stanley Black & Decker

$121.93

-0.69 (-0.56%)

17:14
12/10/18
12/10
17:14
12/10/18
17:14
Initiation
Stanley Black & Decker initiated  »

Stanley Black &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.